Mark D. Orland

Tumor-informed molecular residual disease in resected mucosal and cutaneous squamous cell carcinomas of the head and neck

Abstract Patients with resected mucosal (HNSCC) or cutaneous (cSCC) squamous carcinomas of the head and neck undergo adjuvant therapy based on clinicopathologic prognosticators. Most patients are overtreated or undertreated, with substantial morbidity from locoregional recurrence...